Avidity Biosciences Inc. (RNA)
NASDAQ: RNA
· Real-Time Price · USD
46.46
0.39 (0.85%)
At close: Aug 15, 2025, 3:59 PM
46.91
0.96%
After-hours: Aug 15, 2025, 07:34 PM EDT
Avidity Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -455.74M | -369.22M | -322.3M | -280.49M | -252.45M | -228.68M | -212.22M | -202.25M | -193.49M | -192.15M | -174M | -162.06M | -147.74M | -128.4M | -118.01M | -95.75M | -77.91M | -62.11M |
Depreciation & Amortization | -5.58M | 2.92M | 2.78M | 2.65M | 2.51M | 2.35M | 2.1M | 1.87M | 1.67M | 1.46M | 1.39M | 1.21M | 1.02M | 845K | 639K | 546K | 471K | 398K |
Stock-Based Compensation | 63.64M | 58.79M | 51.36M | 47.05M | 42.78M | 39.42M | 38.22M | 35.68M | 32.95M | 30M | 27.14M | 24.35M | 21.81M | 19.59M | 17.06M | 14.42M | 11.16M | 7.56M |
Other Working Capital | -106.04M | -44.73M | -49.74M | 43.42M | 53.28M | 52.13M | 59.36M | -21.1M | -29.51M | -21.91M | -23.24M | -7.86M | -2.88M | -8.05M | -3.1M | -9.11M | -11.93M | -3.79M |
Other Non-Cash Items | -10.72M | -20.35M | -18.15M | -5.5M | 1.26M | 5.64M | 6.23M | -876K | -1.65M | -1.69M | 16K | 907K | 964K | 303K | 163K | 80K | 1.73M | 1.73M |
Deferred Income Tax | n/a | n/a | n/a | -8.72M | -11.68M | -14.52M | -14.52M | -5.81M | -2.84M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 75K |
Change in Working Capital | -81.57M | -27.46M | -14.56M | 60.5M | 61.91M | 55.31M | 61.13M | -3.38M | -6.57M | 6.66M | 9.13M | 12.24M | 11.77M | 2.95M | 5.34M | -969K | -3.79M | 4.35M |
Operating Cash Flow | -489.98M | -355.32M | -300.87M | -184.5M | -155.67M | -140.48M | -119.06M | -174.75M | -169.92M | -155.66M | -136.27M | -123.29M | -112.12M | -104.71M | -94.81M | -81.67M | -70M | -49.66M |
Capital Expenditures | -12.72M | -9.9M | -7.07M | -4.01M | -3.23M | -3.32M | -4.23M | -4.21M | -3.19M | -3.88M | -2.82M | -3.68M | -4.59M | -3.97M | -3.74M | -2.27M | -2.31M | -1.61M |
Cash Acquisitions | n/a | n/a | n/a | -51.9M | -21.35M | -68.02M | 125.84M | 199.27M | 157.89M | 204.56M | 10.7M | -3.52M | 7.3M | 7.3M | 7.3M | n/a | n/a | n/a |
Purchase of Investments | -1.16B | -1.46B | -1.43B | -1.19B | -699.7M | -351.21M | -461M | -496.84M | -418.68M | -432.47M | -355.84M | -351.55M | -297.92M | -260.07M | -85.36M | -6.69M | -6.69M | -6.69M |
Sales Maturities Of Investments | 971.51M | 806.89M | 586.4M | 455.37M | 414.88M | 387.39M | 335.16M | 312.18M | 275.39M | 226.19M | 168.71M | 88.97M | 24.52M | 6.58M | 6.58M | 3.58M | 3.58M | n/a |
Other Investing Acitivies | n/a | n/a | n/a | 51.9M | 21.35M | 68.02M | -125.84M | -199.27M | -157.89M | -220.88M | -201.74M | -187.52M | -198.34M | -178.44M | -3.72M | -3.11M | -3.11M | -6.69M |
Investing Cash Flow | -203.91M | -664.27M | -854.2M | -738.99M | -288.06M | 32.86M | -130.07M | -188.88M | -146.47M | -210.16M | -189.96M | -266.25M | -277.98M | -257.47M | -82.52M | -5.38M | -5.43M | -8.3M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.98M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 444K | 444K | 444K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 32.93M | 46.6M | 191.81M | 36.19M | 158.88M | 146.07M | 1.39M | 5.11M | 5.41M | 5.05M | 4.54M | 1.19M | -9.54M | -9.63M | -9.62M | -9.55M | -466K | -23.35M |
Financial Cash Flow | 361.9M | 804.85M | 1.19B | 1.21B | 868.1M | 460.35M | 93.86M | 305.63M | 345.21M | 345.02M | 346.17M | 123.23M | 238.78M | 200.41M | 176.32M | 156.05M | -466K | 270.73M |
Net Cash Flow | -331.84M | -214.7M | 37.29M | 287.04M | 424.37M | 352.73M | -155.27M | -58.01M | 28.82M | -20.8M | 19.95M | -266.31M | -151.32M | -161.76M | -1.01M | 69M | -75.9M | 212.77M |
Free Cash Flow | -502.7M | -365.22M | -307.94M | -188.51M | -158.91M | -143.8M | -123.29M | -178.97M | -173.11M | -159.55M | -139.09M | -126.97M | -116.7M | -108.68M | -98.55M | -83.94M | -72.32M | -51.27M |